Shangyi Rong

Research output

Research output per year 2023 2023 2023

• 1 Paper

Research output per year

Research output per year

Search results

• 2023

  Safety, tolerability, pharmacokinetics, and antitumor activity of SHR-A1811 (a HER2-targeting ADC) in HER2-expressing/mutated advanced solid tumors: a global phase 1, multi-center, first-in-human study

  Rong, S., 18 Apr 2023.

  Research output: Contribution to conference › Paper › peer-review